Form 4: NHI Director Exercises Options, Adjusts Holdings

Sentiment:

Insider Transaction Report


A director at National Health Investors Inc. exercised stock options and sold shares for tax withholding purposes in a pre-planned transaction.

Summary

  • Robert A. McCabe Jr., a Director of National Health Investors Inc. (NHI), reported changes in his beneficial ownership.
  • On January 14, 2026, McCabe acquired 25,000 shares of common stock through the exercise of stock options at a price of $69.2 per share.
  • Concurrently, McCabe disposed of 21,836 shares of common stock at $79.23 per share, primarily for tax withholding related to the option exercise.
  • Following these transactions, McCabe's direct beneficial ownership of common stock stands at 38,438.17 shares.
  • The transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: The sentiment is slightly positive to neutral. The exercise of options by a director generally indicates confidence, while the subsequent sale for tax purposes is a common and expected part of such transactions, not necessarily a negative signal about the company's prospects.

Positives

  • The exercise of stock options by a director can signal confidence in the company's future performance and value.
  • The transaction was pre-planned under a Rule 10b5-1(c) plan, indicating a structured approach to insider trading and reducing concerns about opportunistic timing.

Negatives

  • A portion of the acquired shares (21,836 shares) was sold, reducing the director's overall direct beneficial ownership after the option exercise.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: Provides transparency into a director's ownership changes, which can be a minor factor in assessing insider confidence.
  • Reporting Person: Robert A. McCabe Jr.'s direct beneficial ownership of common stock has been adjusted to 38,438.17 shares following these transactions.

Key Dates

DateDescription
02/25/2021Date exercisable for 25,000 stock options with an exercise price of $69.2.
03/03/2025Date exercisable for 10,000 stock options with an exercise price of $73.34.
02/25/2026Expiration date for 25,000 stock options with an exercise price of $69.2.
01/14/2026Date of earliest transaction, involving the exercise of stock options and sale of common stock.
01/16/2026Signature date of the reporting person for the Form 4 filing.
03/03/2030Expiration date for 10,000 stock options with an exercise price of $73.34.

Recommendation

hold

This Form 4 filing details a routine insider transaction involving the exercise of stock options and a subsequent sale for tax purposes, pre-planned under a Rule 10b5-1 plan. Such transactions typically do not reflect a change in the company's fundamental outlook or warrant a shift in investment recommendation. Investors should consider this a standard disclosure rather than a signal for immediate action.

Keywords

National Health Investors, NHI, Form 4, Insider Transaction, Stock Options, Beneficial Ownership, Director, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.